U.S. flag

An official website of the United States government

NM_000490.5(AVP):c.346T>G (p.Cys116Gly) AND Neurohypophyseal diabetes insipidus

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jul 1, 2001
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000013004.17

Allele description [Variation Report for NM_000490.5(AVP):c.346T>G (p.Cys116Gly)]

NM_000490.5(AVP):c.346T>G (p.Cys116Gly)

Gene:
AVP:arginine vasopressin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
20p13
Genomic location:
Preferred name:
NM_000490.5(AVP):c.346T>G (p.Cys116Gly)
HGVS:
  • NC_000020.11:g.3082779A>C
  • NG_008663.1:g.6946T>G
  • NM_000490.5:c.346T>GMANE SELECT
  • NP_000481.2:p.Cys116Gly
  • LRG_715t1:c.346T>G
  • LRG_715:g.6946T>G
  • LRG_715p1:p.Cys116Gly
  • NC_000020.10:g.3063425A>C
  • P01185:p.Cys116Gly
Protein change:
C116G; CYS116GLY
Links:
UniProtKB: P01185#VAR_015277; OMIM: 192340.0017; dbSNP: rs74315383
NCBI 1000 Genomes Browser:
rs74315383
Molecular consequence:
  • NM_000490.5:c.346T>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Neurohypophyseal diabetes insipidus
Synonyms:
Pituitary diabetes insipidus; Diabetes insipidus cranial type; Diabetes Insipidus, Neurogenic; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0007450; MedGen: C0342394; Orphanet: 178029; Orphanet: 30925; OMIM: 125700

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000033249OMIM
no assertion criteria provided
Pathogenic
(Jul 1, 2001)
germlineliterature only

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Identification of two distinct mutations at the same nucleotide position, concomitantly with a novel polymorphism in the vasopressin-neurophysin II gene (AVP-NP II) in two dutch families with familial neurohypophyseal diabetes insipidus.

Abbes AP, Bruggeman B, van Den Akker EL, de Groot MR, Franken AA, Drexhage VR, Engel H.

Clin Chem. 2000 Oct;46(10):1699-702. No abstract available.

PubMed [citation]
PMID:
11017955

Familial neurohypophysial diabetes insipidus in a large Dutch kindred: effect of the onset of diabetes on growth in children and cell biological defects of the mutant vasopressin prohormone.

Nijenhuis M, van den Akker EL, Zalm R, Franken AA, Abbes AP, Engel H, de Wied D, Burbach JP.

J Clin Endocrinol Metab. 2001 Jul;86(7):3410-20.

PubMed [citation]
PMID:
11443218

Details of each submission

From OMIM, SCV000033249.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (2)

Description

In a Dutch family in which familial neurohypophyseal diabetes insipidus (125700) had been diagnosed, Abbes et al. (2000) identified a cysteine (TGC)-to-glycine (GGC) substitution at codon 116 of the AVP gene. Nijenhuis et al. (2001) analyzed the intracellular transport of the mutant vasopressin prohormone in stably transfected cell lines that contained a regulated secretory pathway. Nijenhuis et al. (2001) referred to the mutation as NP85C-G. In 2 children from this kindred they found that growth retardation was an important early sign that responded to substitution therapy with 1-desamino-8-D-arginine vasopressin. To obtain clues about the basis for the dominant inheritance of familial neurohypophyseal diabetes insipidus, they analyzed the trafficking and processing of the mutant vasopressin prohormone in cell lines by metabolic labeling and immunoprecipitation. The mutant vasopressin prohormone was retained in the endoplasmic reticulum and thus was not processed to vasopressin. The defect was not caused by dimerization of the vasopressin prohormone via its unpaired cysteine residue. High-level expression of the mutant vasopressin prohormone in cell lines resulted in strong accumulation in the endoplasmic reticulum and an altered morphology of this organelle. The authors hypothesized that disturbance of the endoplasmic reticulum results in dysfunction and ultimately cell death of the cells expressing the mutant prohormone.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jul 15, 2024